Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-99b-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 232, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
PUM1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.498
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:30932005-30932029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DTNA hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr18:34868254-34868271 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SYNCRIP hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr6:85611460-85611486 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HNRNPA1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:54286583-54286611 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ENPP2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:119557322-119557344 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LRRC1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:53920674-53920693 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KIF11 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.491
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:92613085-92613107 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PPIG hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.682
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:169638190-169638210 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FGF5 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr4:80266805-80266833 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SCAF11 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:45927886-45927907 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SLC15A4 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:128794033-128794052 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUPL1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.555
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr13:25336218-25336241 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC46A3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr13:28700924-28700942 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CUL4A hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr13:113230202-113230223 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TSPAN3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.555
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr15:77046704-77046728 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NCOA2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr8:70155987-70156007 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CRTC3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.470
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr15:90642362-90642384 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZCCHC14 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.855
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr16:87410084-87410103 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MINK1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:4878315-4878341 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CSNK1D hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:82265755-82265777 HITS-CLIP POSITIVE DIRECT TarBase 7.0